Turtle Cameron Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$4.77M

Insider Activity of Turtle Cameron

According to the SEC Form 4 filings, Turtle Cameron, being in a position of

  1. Chief Executive Officer at Spyre Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 176706 shares for $11.15M,
    over all time since 2025-11-03, has bought 0 shares, and sold 221706 shares for $12.2M.

Biography of Turtle Cameron

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $11,146,23312100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0177%
$92.01$1.38M+1.63%
2026-09-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.017%
$87.29$1.31M+1.8%
2026-08-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0044%
$95.51$1.43M-3.72%
2026-07-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0245%
$87.69$1.32M+5.31%
2026-06-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0248%
$70.43$1.06M+29.98%
2026-06-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
11,706
0.0193%
$70.17$821,360+29.98%
2026-05-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0247%
$71.37$1.07M+29.71%
2026-04-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0251%
$49.33$739,912+80.65%
2026-03-02SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0244%
$42.19$632,866+101.91%
2026-02-02SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0249%
$32.80$492,045+146.14%
2026-01-02SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0233%
$30.68$460,134+148.46%
2025-12-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
15,000
0.0251%
$29.02$435,356+156.49%
2025-11-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Executive Officer
45,000
0.0711%
$23.33$1.05M+202.44%
2020-12-28SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
19,500
0.0166%
$69.60$1.36M-20.39%
2020-11-25SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
742
0.0006%
$47.23$35,044+16.18%
2020-11-24SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
4,258
0.0036%
$47.00$200,137+19.85%
2020-11-05SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
2,500
0.0022%
$42.05$105,125+37.36%
2020-09-30SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
16,558
0.0141%
$37.76$625,165+50.07%
2020-09-18SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
5,000
0.003%
$29.50$147,524+33.47%
2020-09-15SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
5,000
0.0031%
$27.03$135,152+52.22%
Total: 26
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.